Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Celldex Therapeutics to Present at Two Upcoming Investor Conferences



Celldex Therapeutics to Present at Two Upcoming Investor Conferences

NEEDHAM, Mass., May 22, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc.
(Nasdaq:CLDX) announced today that Anthony Marucci, President and Chief
Executive Officer, will present a corporate overview at the Deutsche Bank
38^th Annual Healthcare Conference in Boston on May 29, 2013 at 4:10 p.m. ET
and at the Jefferies 2013 Global Healthcare Conference on June 5, 2013 at 9:30
a.m. ET in New York City.

The live webcasts of the presentations will be available online on the "Events
& Presentations" page of the "Investors & Media" section of the Celldex
website. Replays of the presentations will be available for 30 days following
each event.

About Celldex Therapeutics, Inc.

Celldex is developing targeted therapeutics to address devastating diseases
for which available treatments are inadequate. Our pipeline is built from a
proprietary portfolio of antibodies and immunomodulators used alone and in
strategic combinations to create novel, disease-specific therapies that
induce, enhance or suppress the body's immune response. Visit
http://www.celldextherapeutics.com.

CONTACT: Sarah Cavanaugh
         Vice President of Investor Relations &
         Corp Communications
         Celldex Therapeutics, Inc.
         (781) 433-3161
         scavanaugh@celldextherapeutics.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement